English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Improvements of cognition and activities of daily living in galantamine-treated patients with probable Alzheimer's disease: A large-scale observational study.

MPS-Authors
/persons/resource/persons147206

Kalbe,  Elke
Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147210

Kessler,  Josef
Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Kalbe, E., Kessler, J., & Schwalen, S. (2003). Improvements of cognition and activities of daily living in galantamine-treated patients with probable Alzheimer's disease: A large-scale observational study. European Journal of Neurology, 10(Suppl.1), 160-161.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-D5CF-D
Abstract
Copyright 2003 Blackwell Publ.